US EditionPublished • loading... • Updated
Lewy Body Disease, Then Parkinson's or Alzheimer's: Clinatec Fund Launches Clinical Trial of a Photobiomodulation Helmet to Treat Neurodegenerative Diseases with Light
Summary by usinenouvelle.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The light to treat neurodegenerative diseases. This is the promise of the Clinatec Fund, a project accelerator, separate from the Clinatec biomedical research centre located in Grenoble (Isère), and its photobiomodulation helmet. For the first time, this helmet is used with the University Hospitals of Strasbourg (Bas-Rhin) as part of a double-blind clinical trial on thirty or so patients with Lewy's body disease, announces the Clinatec Fund on F…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
